World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
47
Citations
7527
World Ranking
4812
National Ranking
1856

Thomas Kieber-Emmons publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Thomas Kieber-Emmons sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 226 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Thomas Kieber-Emmons D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas Kieber-Emmons sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Thomas Kieber-Emmons is affiliated with the University of Arkansas for Medical Sciences in the United States. Their research spans multiple disciplines primarily within medicine, immunology, and molecular biology, with a focus on immunotherapy and immune responses, cancer immunotherapy, monoclonal and polyclonal antibodies, and infectious diseases.

The main fields of study for Kieber-Emmons include Medicine with 36 publications, Immunology and Microbiology with 24, and Biochemistry, Genetics, and Molecular Biology totaling 21 publications. Subfields are centered on Immunology (23 publications), Molecular Biology (14), Infectious Diseases (13), Oncology (10), and Radiology, Nuclear Medicine, and Imaging (8).

Key topics addressed in their research involve:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • Vaccines and Immunoinformatics Approaches
  • Glycosylation and Glycoproteins Research
  • Toxin Mechanisms and Immunotoxins

Thomas Kieber-Emmons has contributed frequently to the journal Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, with 21 published works. Other venues where their research appears include Cancer Research (5 publications), Oncotarget, Pharmacology, and the International Journal of Molecular Sciences.

Some of the recent research papers authored or co-authored by Kieber-Emmons include:

  • "P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses" (2021), published in Oncotarget
  • "Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells" (2020), published in Pharmacology
  • "VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen" (2023), published in International Journal of Molecular Sciences
  • "Expert Panel Discussion on Antigenic Sin" (2021), published in Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
  • "Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study" (2020), published in Frontiers in Oncology

Frequent collaborators working with Kieber-Emmons include Behjatolah Monzavi-Karbassi, Fariba Jousheghany, Eric R. Siegel, Issam Makhoul, and Bernice Nounamo.

Best Publications

  • Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides.

    R R Vassallo;T Kieber-Emmons;K Cichowski;L F Brass

  • Adjuvant‐dependent modulation of Th1 and Th2 responses to immunization with β‐amyloid

    David H. Cribbs;Anahit Ghochikyan;Vitaly Vasilevko;Mike Tran

  • Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.

    Sundarasamy Mahalingam;Velpandi Ayyavoo;Mamata Patel;Thomas Kieber-Emmons

  • Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells

    Craig A Cooney;Fariba Jousheghany;Aiwei Yao-Borengasser;Bounleut Phanavanh

  • Peptide mimicry of the meningococcal group C capsular polysaccharide.

    M. A. J. Westerink;P. C. Giardina;M. A. Apicella;T. Kieber-Emmons

  • Design of bioactive peptides based on antibody hypervariable region structures. Development of conformationally constrained and dimeric peptides with enhanced affinity.

    W V Williams;T Kieber-Emmons;J VonFeldt;M I Greene

  • Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses

    Kieber-Emmons T;Luo P;Qiu J;Chang Ty

  • Defining an Antigenic Epitope on Platelet Factor 4 Associated With Heparin-Induced Thrombocytopenia

    L. Ziporen;Z.Q. Li;K.S. Park;P. Sabnekar

  • Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide.

    Chang-Yuil Kang;T. K. Brunck;T. Kieber-Emmons;J. E. Blalock

  • AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease.

    W.John W. Morrow;David A. Isenberg;Robert E. Sobol;Raphael B. Stricker

  • Development of biologically active peptides based on antibody structure

    William V. Williams;David A. Moss;Thomas Kieber-Emmons;Jeffrey A. Cohen

  • Therapeutic peptides and peptidomimetics.

    Thomas Kieber-Emmons;Ramachandran Murali;Mark I Greene

  • HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle

    Sundarasamy Mahalingam;Velpandi Ayyavoo;Mamata Patel;Thomas Kieber-Emmons

  • Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus

    M. Agadjanyan;P. Luo;M. A. J. Westerink;L. A. Carey

  • Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library.

    Matthew C Grothaus;Neeti Srivastava;S.Louise Smithson;Thomas Kieber-Emmons

  • Idiotypic networks and nature of molecular mimicry: an overview

    H. Köhler;S. Kaveri;T. Kieber-Emmons;W. J. W. Morrow

  • Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/antireceptor antibody: Modeling of their three-dimensional structures

    W. V. Williams;H. R. Guy;D. H. Rubin;F. Robey

  • Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery.

    Behjatolah Monzavi-Karbassi;Gina Cunto-Amesty;Ping Luo;Thomas Kieber-Emmons

  • Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer

    Angela Pennisi;Thomas Kieber-Emmons;Issam Makhoul;Laura Hutchins

  • Chondroitin sulfate glycosaminoglycans as major P‐selectin ligands on metastatic breast cancer cell lines

    Behjatolah Monzavi-Karbassi;J. Steven Stanley;Leah Hennings;Fariba Jousheghany

  • Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine.

    Jong J Kim;Neil N Trivedi;Darren M Wilson;Sundarasamy Mahalingam

Frequent Co-Authors

David B. Weiner
David B. Weiner The Wistar Institute
William V. Williams
William V. Williams GlaxoSmithKline (United Kingdom)
Ramachandran Murali
Ramachandran Murali Cedars-Sinai Medical Center
Mark I. Greene
Mark I. Greene University of Pennsylvania
Kenneth E. Ugen
Kenneth E. Ugen University of South Florida
Eivind Hovig
Eivind Hovig University of Oslo
Soldano Ferrone
Soldano Ferrone Harvard University
Sanford J. Shattil
Sanford J. Shattil University of California, San Diego
Mortimer Poncz
Mortimer Poncz Children's Hospital of Philadelphia
Jean D. Boyer
Jean D. Boyer Inovio Pharmaceuticals (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various health and science-related careers, many of which can be enhanced through specialized online programs. For those interested in the administrative side of healthcare, a bachelor of science in health information management salary reflects the rewarding potential in this growing field.

Accreditation is crucial when selecting an online program. Students seeking credibility and industry recognition should explore cahiim accredited him degree online options, ensuring their education meets high standards and enhances employability.

For those aiming for quicker entry into healthcare support roles, the shortest online medical billing and coding certificate programs provide an efficient pathway. These programs equip students with essential skills to manage healthcare data and billing efficiently.

Furthermore, the scope of online medical programs continues to expand, offering flexible learning opportunities in various medical fields. These programs complement a microbiology background and pave the way for diverse career pathways within the healthcare sector.

Best Scientists Citing Thomas Kieber-Emmons

Trending Scientists

Recently Published Articles